Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2026 Filed Jan 16, 2026 18:05 UTC |
Marquet MagdaDirector
|
SaleCommon Stock | 9,290 | $48.12 | $446,999.50 |
DisclosureSEC source: 0001631486-26-000002 · form4-01162026_010101.xml · nonDerivative · entry 2 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,640 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.595 to $48.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 18:05 UTC |
Marquet MagdaDirector
|
Exercise / conversionCommon Stock | 11,000 | $26.11 | $287,210.00 |
DisclosureSEC source: 0001631486-26-000002 · form4-01162026_010101.xml · nonDerivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 00:16 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 3,650 | $44.71 | $163,191.50 |
DisclosureSEC source: 0001711462-26-000006 · form4-01102026_120159.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,088 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 00:12 UTC |
Faga DanielDirector · President, CEO
|
SaleCommon Stock | 14,281 | $44.71 | $638,503.51 |
DisclosureSEC source: 0001673528-26-000006 · form4-01102026_120114.xml · nonDerivative · entry 2 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,344 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 19:13 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 2,210 | $44.71 | $98,809.10 |
DisclosureSEC source: 0001239648-26-000006 · form4-01102026_120125.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,835 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 00:14 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 2,515 | $44.71 | $112,445.65 |
DisclosureSEC source: 0001276840-26-000006 · form4-01102026_120148.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,852 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:11 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 2,235 | $45.11 | $100,820.85 |
DisclosureSEC source: 0001711462-26-000004 · form4-01082026_090121.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,213 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:10 UTC |
Faga DanielDirector · President, CEO
|
SaleCommon Stock | 9,202 | $45.11 | $415,102.22 |
DisclosureSEC source: 0001673528-26-000004 · form4-01082026_090111.xml · nonDerivative · entry 2 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,787 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 500 | $47.23 | $23,615.00 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 5 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,157 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 1,841 | $46.13 | $84,925.51 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,657 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.96 to $46.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 5,281 | $45.38 | $239,672.38 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,498 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.87 to $45.835 per share, inclusive. The reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
SaleCommon Stock | 2,017 | $45.11 | $90,986.87 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,779 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:08 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,908 | $45.11 | $86,069.88 |
DisclosureSEC source: 0001276840-26-000004 · form4-01082026_090154.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,667 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 07, 2026 Filed Jan 10, 2026 00:16 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001711462-26-000006 · form4-01102026_120159.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,575 Underlying: Common Stock · 8,525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 10, 2026 00:16 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 8,525 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001711462-26-000006 · form4-01102026_120159.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 07, 2026 Filed Jan 10, 2026 00:12 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 26,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001673528-26-000006 · form4-01102026_120114.xml · derivative · entry 3 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,512 Underlying: Common Stock · 26,838 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 10, 2026 00:12 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionCommon Stock | 26,838 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001673528-26-000006 · form4-01102026_120114.xml · nonDerivative · entry 1 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 19:13 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001239648-26-000006 · form4-01102026_120125.xml · derivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,662 Underlying: Common Stock · 5,888 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 19:13 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 5,888 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001239648-26-000006 · form4-01102026_120125.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 07, 2026 Filed Jan 10, 2026 00:14 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001276840-26-000006 · form4-01102026_120148.xml · derivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 6,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 07, 2026 Filed Jan 10, 2026 00:14 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 6,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001276840-26-000006 · form4-01102026_120148.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:03 UTC |
Ware J. AnthonyDirector
|
GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001715429-26-000001 · form4-01082026_090158.xml · derivative · entry 2 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:03 UTC |
Ware J. AnthonyDirector
|
GrantStock Option (right to buy) · Derivative | 5,500 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001715429-26-000001 · form4-01082026_090158.xml · derivative · entry 1 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:11 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 29,000 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001711462-26-000004 · form4-01082026_090121.xml · derivative · entry 5 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,000 Underlying: Common Stock · 29,000 shares Expires 2036-01-05 F5 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:11 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001711462-26-000004 · form4-01082026_090121.xml · derivative · entry 4 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,400 Underlying: Common Stock · 21,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:11 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001711462-26-000004 · form4-01082026_090121.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,145 Underlying: Common Stock · 6,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:11 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 6,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001711462-26-000004 · form4-01082026_090121.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:10 UTC |
Faga DanielDirector · President, CEO
|
GrantStock Option (right to buy) · Derivative | 133,400 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001673528-26-000004 · form4-01082026_090111.xml · derivative · entry 5 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,400 Underlying: Common Stock · 133,400 shares Expires 2036-01-05 F5 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:10 UTC |
Faga DanielDirector · President, CEO
|
GrantRestricted Stock Unit · Derivative | 98,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001673528-26-000004 · form4-01082026_090111.xml · derivative · entry 4 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,600 Underlying: Common Stock · 98,600 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:10 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001673528-26-000004 · form4-01082026_090111.xml · derivative · entry 3 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,850 Underlying: Common Stock · 17,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:10 UTC |
Faga DanielDirector · President, CEO
|
Exercise / conversionCommon Stock | 17,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001673528-26-000004 · form4-01082026_090111.xml · nonDerivative · entry 1 Faga Daniel · CIK 0001673528 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 475,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:04 UTC |
Schmid John P.Director
|
GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001478916-26-000001 · form4-01082026_090159.xml · derivative · entry 2 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:04 UTC |
Schmid John P.Director
|
GrantStock Option (right to buy) · Derivative | 5,500 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001478916-26-000001 · form4-01082026_090159.xml · derivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:02 UTC |
Orwin John ADirector
|
GrantRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477384-26-000001 · form4-01082026_090106.xml · derivative · entry 2 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:02 UTC |
Orwin John ADirector
|
GrantStock Option (right to buy) · Derivative | 8,250 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001477384-26-000001 · form4-01082026_090106.xml · derivative · entry 1 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,250 Underlying: Common Stock · 8,250 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 23,200 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · derivative · entry 8 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,200 Underlying: Common Stock · 23,200 shares Expires 2036-01-05 F8 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
GrantRestricted Stock Unit · Derivative | 17,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · derivative · entry 7 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,100 Underlying: Common Stock · 17,100 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F7 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · derivative · entry 6 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,545 Underlying: Common Stock · 5,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 16:12 UTC |
LOUMEAU ERIC JCHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 5,545 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:07 UTC |
FENTON DENNIS MDirector
|
GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001184627-26-000001 · form4-01082026_090118.xml · derivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:07 UTC |
FENTON DENNIS MDirector
|
GrantStock Option (right to buy) · Derivative | 5,500 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001184627-26-000001 · form4-01082026_090118.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
RENTON HOLLINGSDirector
|
GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001187333-26-000001 · form4-01082026_090157.xml · derivative · entry 2 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
RENTON HOLLINGSDirector
|
GrantStock Option (right to buy) · Derivative | 5,500 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001187333-26-000001 · form4-01082026_090157.xml · derivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:08 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 29,000 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001276840-26-000004 · form4-01082026_090154.xml · derivative · entry 5 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,000 Underlying: Common Stock · 29,000 shares Expires 2036-01-05 F5 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:08 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Unit · Derivative | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001276840-26-000004 · form4-01082026_090154.xml · derivative · entry 4 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,400 Underlying: Common Stock · 21,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:08 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001276840-26-000004 · form4-01082026_090154.xml · derivative · entry 3 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,245 Underlying: Common Stock · 5,245 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:08 UTC |
MULROY DENNISCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 5,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001276840-26-000004 · form4-01082026_090154.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:06 UTC |
Jain RitaDirector
|
GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001707797-26-000001 · form4-01082026_090134.xml · derivative · entry 2 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:06 UTC |
Jain RitaDirector
|
GrantStock Option (right to buy) · Derivative | 5,500 | $0.00 Strike: $43.91 | $0.00 |
DisclosureSEC source: 0001707797-26-000001 · form4-01082026_090134.xml · derivative · entry 1 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
Marquet MagdaDirector
|
GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001631486-26-000001 · form4-01082026_090143.xml · derivative · entry 2 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.